$127.28 -2.75 (%) Medivation Inc - NASDAQ

Mar. 26, 2015 | 10:10 AM

Partner Headlines

  1. Four Hot Stocks You'll Want To Keep On Your Radar

    IBD | Feb. 27, 2015 | 17:44PM EST
  2. Nasdaq, S&P 500 Hang Tough; Avago, Akorn Big Earnings Winners

    IBD | Feb. 26, 2015 | 12:12PM EST
  3. Medivation Tops Q4 Views On Strong Xtandi Results

    IBD | Feb. 26, 2015 | 09:56AM EST
  4. Stocks Mixed; United Therapeutics Jumps To New High

    IBD | Feb. 25, 2015 | 14:59PM EST
  5. Market Edges Higher, Unfazed By Weak HP Results

    IBD | Feb. 25, 2015 | 13:31PM EST
  6. Market's Resilience Is Noteworthy; More Breakouts Emerge

    IBD | Feb. 25, 2015 | 11:55AM EST
  7. Earnings Scheduled For February 25, 2015

    Benzinga | Feb. 25, 2015 | 04:07AM EST
  8. Stocks Show Small Losses; Merger Talk Lifts Discovery

    IBD | Feb. 23, 2015 | 15:05PM EST
  9. Stocks Quietly Lower; Domino's, Medivation Break Out

    IBD | Feb. 23, 2015 | 13:18PM EST
  10. Wedbush Weighs in on Medivation Following Phase II TERRAIN Study Results

    GuruFocus | Feb. 3, 2015 | 12:50PM EST
  11. Valeant Agrees To Buy Dendreon's Provenge

    IBD | Jan. 30, 2015 | 11:39AM EST
  12. Weekly CEO Sells Highlight: QAD Inc, Orbitz Worldwide Inc, Constellation Brands Inc, and ...

    GuruFocus | Jan. 25, 2015 | 23:19PM EST
  13. Enzalutamide Phase 2 Terrain Trial Demonstrated Statistically Significant Increase in PFS as ...

    GuruFocus | Jan. 22, 2015 | 11:05AM EST
  14. J&J Earnings Beat, But Sales, Guidance Miss Estimates

    IBD | Jan. 20, 2015 | 11:20AM EST
  15. Eli Lilly Has 'Turned The Corner,' Upgraded

    IBD | Jan. 15, 2015 | 11:02AM EST
  16. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1

    Benzinga | Jan. 12, 2015 | 08:55AM EST
  17. Barclays Analyst Sees Biotech FY15 EPS Growth Outstripping Market

    Benzinga | Jan. 6, 2015 | 12:21PM EST
  18. William Blair's Top BioPharmaceutical Stock Picks for Q1 2015

    GuruFocus | Dec. 23, 2014 | 14:47PM EST
  19. Newly Profitable Medivation Riding High On Drug Sales

    IBD | Nov. 28, 2014 | 17:20PM EST
  20. Chip Stocks, Biotechs Lead Another Nasdaq Rally

    IBD | Nov. 24, 2014 | 14:58PM EST
  21. Major Upgrades And Downgrades In Friday's Market Action

    Benzinga | Nov. 7, 2014 | 15:30PM EST
  22. Medivation Hits High After Q3 Earnings Beat

    IBD | Nov. 7, 2014 | 11:15AM EST
  23. Medivation Hits High After Q3 Earnings Beat

    IBD | Nov. 7, 2014 | 11:15AM EST
  24. Medivation and Astellas Announce Phase 3 Study of Enzalutamide in Men With High-Risk, ...

    GuruFocus | Oct. 31, 2014 | 01:02AM EST
  25. J&J Earnings Beat; Olysio Chatter Hits Gilead

    IBD | Oct. 14, 2014 | 11:54AM EST
  26. Consider Medivation for Your Portfolio

    FoxBusiness | Oct. 6, 2014 | 13:31PM EST
  27. Benzinga's Top Downgrades

    Benzinga | Sep. 24, 2014 | 08:52AM EST
  28. Goldman Sachs Downgrades Medivation To Neutral, Shares Drop

    Benzinga | Sep. 24, 2014 | 08:38AM EST
  29. These 3 Biotech Stocks Just Hit New Highs

    Benzinga | Sep. 22, 2014 | 13:31PM EST
  30. Fast Money Halftime Report Final Trade From September 12

    Benzinga | Sep. 12, 2014 | 22:04PM EST
  31. Medivation Eyes Blockbuster As Cancer Drug Gets An OK

    IBD | Sep. 11, 2014 | 17:41PM EST
  32. Stifel Raises Medivation Inc Price Target

    Benzinga | Sep. 11, 2014 | 08:32AM EST
  33. Stocks Hitting 52-Week Highs

    Benzinga | Sep. 10, 2014 | 10:05AM EST
  34. A Few Reasons Why Investors Should Consider Dendreon for Their Portfolio

    GuruFocus | Aug. 15, 2014 | 12:18PM EST
  35. Medivation Cancer Drug Fuels Beat, Swings To Profit

    IBD | Aug. 8, 2014 | 11:55AM EST
  36. Benzinga's Volume Movers

    Benzinga | Aug. 8, 2014 | 10:32AM EST
  37. Medivation Announces Change in Executive Management Team; Dawn Svoronos To Chief Commercial Officer

    Benzinga | Jul. 10, 2014 | 16:11PM EST
  38. Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector

    Benzinga | Jul. 3, 2014 | 12:26PM EST
  39. Aegis Capital Believes Seragon Deal Underscores Value In Medivation

    Benzinga | Jul. 2, 2014 | 10:28AM EST
  40. UPDATE: Stifel Reiterates On Medivation Following Prostate Cancer Survey

    Benzinga | Jun. 23, 2014 | 09:33AM EST
  41. Benzinga's Top Upgrades

    Benzinga | Jun. 19, 2014 | 07:46AM EST
  42. US Stock Futures Flat Ahead Of International Trade Data

    Benzinga | May. 6, 2014 | 07:29AM EST
  43. UPDATE: Canaccord Genuity Initiates Coverage on Medivation as Urologist Uptake is Unclear

    Benzinga | Apr. 16, 2014 | 09:45AM EST
  44. Morning Market Movers

    Benzinga | Apr. 1, 2014 | 09:43AM EST
  45. Stocks To Watch For April 1, 2014

    Benzinga | Apr. 1, 2014 | 04:22AM EST
  46. Celegene, Pharmacyclics Lead Biotech Short Interest Trend (CELG, MDVN, PCYC)

    Benzinga | Mar. 26, 2014 | 07:56AM EST
  47. UPDATE: Astellas Announces Marketing Approval in Japan for XTANDI® (enzalutamide) Capsules, an Advanced Prostate Cancer Treatment

    Benzinga | Mar. 24, 2014 | 16:11PM EST
  48. BioMarin, Medivation Buck Biotech Short Interest Trend (BIIB, BMRN, MDVN)

    Benzinga | Mar. 12, 2014 | 10:01AM EST
  49. Market Wrap For February 28: Markets Unable To Hold On To Gains

    Benzinga | Feb. 28, 2014 | 16:53PM EST
  50. Mornings Movers for Feb. 28, 2014: CETV, OTVI, MELI, REGI, GALE Moving Higher, ELGX, DECK, MDVN, CGEN, ARNA Lowr

    Benzinga | Feb. 28, 2014 | 10:40AM EST
Trading Center